Skip to Main Content

Author Details

Michiyo Sakiyama
the Lifestyle Related Disease Medical Center
2000
22
9
PMIDPaper TitleJournal TitlePublished Year
36696644Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis.Menopause2023
35471559Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases.Ther Innov Regul Sci2022
31937606Big Data in the Assessment of Pediatric Medication Safety.Pediatrics2020
30924233Pediatric drug regulation: International perspectives.Paediatr Anaesth2019
29288517Proposal for the development of biologics in pediatric rheumatology.Pediatr Int2018
21237394Rituximab-containing therapy for chronic lymphocytic leukaemia.Lancet2011
21646775[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].Rinsho Ketsueki2011
21042310TBI and melphalan followed by allogeneic hematopoietic SCT in children with advanced hematological malignancies.Bone Marrow Transplant2011
18026150Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children.Bone Marrow Transplant2008
17172587Chronic diarrhoea with thickening of the colonic wall.Gut2007
16622753Intensive multimodality therapy including paclitaxel and reduced-intensity allogeneic hematopoietic stem cell transplantation in the treatment of adrenal cancer with multiple metastases.Int J Clin Oncol2006
15765112Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation.Bone Marrow Transplant2005
15699774A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.Transplantation2005
14676774Urgent need for a validated tumor response evaluation system for use in immunotherapy.Bone Marrow Transplant2004
15361909Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0.Bone Marrow Transplant2004
14752781Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.Biol Blood Marrow Transplant2004
15048142Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.Bone Marrow Transplant2004
12819836Pyomyositis of the vastus medialis muscle associated with Salmonella enteritidis in a child.Pediatr Radiol2003
14738303Fatal pulmonary thromboembolism after a second course of high-dose chemotherapy with autologous peripheral blood stem cell transplantation.Pediatr Transplant2003
12900783Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant2003
12660521Life-threatening hypothyroidism associated with administration of cyclosporine in a patient treated with reduced-intensity hematopoietic stem-cell transplantation for metastatic renal-cell carcinoma.Transplantation2003
111925293beta-hydroxy-delta5-C27-steroid dehydrogenase/isomerase deficiency in a 23-year-old woman.Pediatr Int2000
  • 1 - 22 of 22

Recommended Authors

University of Arizona
Career Start Year 2011
Number of shared co-authors 0
University of Tennessee Health Science Center
Career Start Year 2009
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
University Hospital Carl Gustav Carus, Technische Universitat Dresden
Career Start Year 2007
Number of shared co-authors 0
MedStar Washington Hospital Center
Career Start Year 2006
Number of shared co-authors 0
University of Manitoba
Career Start Year 2005
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 2004
Number of shared co-authors 0
Oregon Health Sciences University
Career Start Year 2002
Number of shared co-authors 0
Tuen Mun Hospital
Career Start Year 1999
Number of shared co-authors 0
Medical University of Graz
Career Start Year 1998
Number of shared co-authors 0
Merck & Co.
Career Start Year 1998
Number of shared co-authors 0
College of Nursing
Career Start Year 1997
Number of shared co-authors 0
School of Clinical Medicine, University of Hong Kong
Career Start Year 1997
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1997
Number of shared co-authors 0
Dana Farber Cancer Institute/Boston Children's Hospital
Career Start Year 1996
Number of shared co-authors 0
Great Ormond Street Hospital for Children NHS Foundation Trust
Career Start Year 1995
Number of shared co-authors 0
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 0
Ann & Robert H. Lurie Children's Hospital of Chicago
Career Start Year 1990
Number of shared co-authors 0
Duke University Medical Center
Career Start Year 1990
Number of shared co-authors 0
Center for Biologics Evaluation and Research
Career Start Year 1988
Number of shared co-authors 1
University of Texas Southwestern Medical Center
Career Start Year 1987
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1987
Number of shared co-authors 0
Cancer and Blood Disease Institute, Children's Hospital Los Angeles
Career Start Year 1986
Number of shared co-authors 0
Flinders University Library, Flinders University
Career Start Year 1985
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1983
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 0
Tufts Medical Center
Career Start Year 1981
Number of shared co-authors 0
Technische Universitat Munchen
Career Start Year 1981
Number of shared co-authors 0
University Hospital Essen, University of Duisburg-Essen
Career Start Year 1979
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Medical Governance Research Institute
Co-authored papers 9
From the National Institutes of Health
Co-authored papers 1
The Institute of Medical Science, The University of Tokyo
Co-authored papers 1
Children's Mercy Hospital
Co-authored papers 1
BC Children's Hospital Research Institute
Co-authored papers 1
Harvard University
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 1
Kyoto University
Co-authored papers 1
School of Pharmacy, Tokyo University of Pharmacy and Life Sciences
Co-authored papers 1
Vanderbilt University School of Medicine
Co-authored papers 1
University Medical Center Utrecht
Co-authored papers 1
Duke University, Emory University, Society for Critical Care Medicine, University of Ontario Institute of Technology, University of Tennessee Health Science Center
Co-authored papers 1
Center for Drug Evaluation and Research
Co-authored papers 1
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 1
Institute of Translational Medicine, University of Liverpool
Co-authored papers 1
Children's Mercy Hospitals and Clinics
Co-authored papers 1